Infectious Disease Doctors in Gallup, NM Accepting Medicare

3 Infectious Disease doctors found. Showing 1 - 3

Sonya Sunhi Shin, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 516 East Nizhoni Blvd., Gallup, NM 87301 Phone: 505-722-1000    Fax: 505-726-8557

Christopher Gonzaga, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2111 College Dr, Rehoboth Mckinley Christian Health Care Services, Gallup, NM 87301 Phone: 505-863-1820

Alithea Dolores Gabrellas, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 516 E Nizhoni Blvd, Gallup, NM 87301 Phone: 505-722-1000

News Archive

People who donate a kidney to help someone else often suffer financially to do so

Living organ donors, through their altruistic act to improve the health of others, may experience substantial economic losses in a variety of cost categories.

Researchers explore ways to design changes in living environment for older adults with dementia

As the population ages and demography changes, the UK is facing an unprecedented challenge of how to care for and support its older people.

Attachment to parents unaffected in offspring of bipolar disorder patients

Children born to families where at least one parent has bipolar disorder do not show abnormalities in attachment compared with other children, say Canadian researchers.

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK.

Early monoclonal antibody therapies beneficial for COVID-19, finds study

A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate COVID-19. The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19.

Read more Medical News

› Verified 3 days ago